The ICD-11 classification of personality disorders: a European perspective on challenges and opportunities

B Bach, U Kramer, S Doering, E di Giacomo… - … Personality Disorder and …, 2022 - Springer
The 11th revision of the World Health Organization (WHO) International Classification of
Diseases (ICD-11) includes a fundamentally new approach to Personality Disorders (PD) …

The prevalence of personality disorders in the community: a global systematic review and meta-analysis

C Winsper, A Bilgin, A Thompson… - The British Journal of …, 2020 - cambridge.org
BackgroundPersonality disorders are now internationally recognised as a mental health
priority. Nevertheless, there are no systematic reviews examining the global prevalence of …

Borderline personality disorder: a review

F Leichsenring, N Heim, F Leweke, C Spitzer… - JAMA, 2023 - jamanetwork.com
Importance Borderline personality disorder (BPD) affects approximately 0.7% to 2.7% of
adults in the US. The disorder is associated with considerable social and vocational …

Pharmacotherapy for borderline personality disorder: an update of published, unpublished and ongoing studies

J Stoffers-Winterling, OJ Storebø, K Lieb - Current Psychiatry Reports, 2020 - Springer
Abstract Purpose of the Review We aim to identify the most recent evidence of randomised
controlled trials evaluating continued drug treatments in people with a diagnosis of BPD …

Pharmacological management of borderline personality disorder and common comorbidities

JC Pascual, L Arias, J Soler - CNS drugs, 2023 - Springer
Comorbidity between borderline personality disorder (BPD) and other mental disorders is
common. Although no specific pharmacological treatments have been approved for the …

Comparative effectiveness of pharmacotherapies for the risk of attempted or completed suicide among persons with borderline personality disorder

J Lieslehto, J Tiihonen, M Lähteenvuo… - JAMA network …, 2023 - jamanetwork.com
Importance Suicidal behavior is a significant clinical concern in individuals with borderline
personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide …

Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies

F Leichsenring, P Fonagy, N Heim… - World …, 2024 - Wiley Online Library
Borderline personality disorder (BPD) was introduced in the DSM‐III in 1980. From the DSM‐
III to the DSM‐5, no major changes have occurred in its defining criteria. The disorder is …

Gender differences in borderline personality disorder: a narrative review

P Bozzatello, C Blua, D Brandellero… - Frontiers in …, 2024 - frontiersin.org
Borderline personality disorder (BPD) is a severe and complex mental disorder that
traditionally has been found to be more frequent in the female gender in clinical samples …

Association of pharmacological treatments and real‐world outcomes in borderline personality disorder

J Lieslehto, J Tiihonen, M Lähteenvuo… - Acta Psychiatrica …, 2023 - Wiley Online Library
Objective Most patients with borderline personality disorder (BPD) receive
psychopharmacological treatment, but clinical guidelines on BPD lack consensus on the …

Therapeutic and preventive interventions in adolescents with borderline personality disorder: recent findings, current challenges, and future directions

N Bourvis, D Cohen, X Benarous - Journal of Clinical Medicine, 2023 - mdpi.com
Background: Borderline personality disorder (BPD) has long suffered from overshadowing in
adolescents and hopelessness from the psychiatrists themselves. Comprehensive …